CLINICAL_TRIALS
research
· 2026-03-11
Clinical Trial Update: Asciminib With or Without Sildenafil for Brain Tumors [EARLY_Phase 1]
Summary
An early Phase 1 trial at Washington University is evaluating asciminib with or without sildenafil for brain tumors; the study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Brain Tumor | EARLY_Phase 1 | Status: NOT_YET_RECRUITING